169 related articles for article (PubMed ID: 33988317)
1. Colonic epithelial cathelicidin (LL-37) expression intensity is associated with progression of colorectal cancer and presence of CD8
Porter RJ; Murray GI; Alnabulsi A; Humphries MP; James JA; Salto-Tellez M; Craig SG; Wang JM; Yoshimura T; McLean MH
J Pathol Clin Res; 2021 Sep; 7(5):495-506. PubMed ID: 33988317
[TBL] [Abstract][Full Text] [Related]
2. MUC2 Mucin and Butyrate Contribute to the Synthesis of the Antimicrobial Peptide Cathelicidin in Response to Entamoeba histolytica- and Dextran Sodium Sulfate-Induced Colitis.
Cobo ER; Kissoon-Singh V; Moreau F; Holani R; Chadee K
Infect Immun; 2017 Mar; 85(3):. PubMed ID: 28069814
[TBL] [Abstract][Full Text] [Related]
3. Heterogeneous expression of human cathelicidin hCAP18/LL-37 in inflammatory bowel diseases.
Schauber J; Rieger D; Weiler F; Wehkamp J; Eck M; Fellermann K; Scheppach W; Gallo RL; Stange EF
Eur J Gastroenterol Hepatol; 2006 Jun; 18(6):615-21. PubMed ID: 16702850
[TBL] [Abstract][Full Text] [Related]
4. The Different Immune Profiles of Normal Colonic Mucosa in Cancer-Free Lynch Syndrome Carriers and Lynch Syndrome Colorectal Cancer Patients.
Bohaumilitzky L; Kluck K; Hüneburg R; Gallon R; Nattermann J; Kirchner M; Kristiansen G; Hommerding O; Pfuderer PL; Wagner L; Echterdiek F; Kösegi S; Müller N; Fischer K; Nelius N; Hartog B; Borthwick G; Busch E; Haag GM; Bläker H; Möslein G; von Knebel Doeberitz M; Seppälä TT; Ahtiainen M; Mecklin JP; Bishop DT; Burn J; Stenzinger A; Budczies J; Kloor M; Ahadova A
Gastroenterology; 2022 Mar; 162(3):907-919.e10. PubMed ID: 34863788
[TBL] [Abstract][Full Text] [Related]
5. IL-27 induces LL-37/CRAMP expression from intestinal epithelial cells: implications for immunotherapy of
Xu B; Wu X; Gong Y; Cao J
Gut Microbes; 2021; 13(1):1968258. PubMed ID: 34432564
[No Abstract] [Full Text] [Related]
6. Expression of human cathelicidin peptide LL-37 in inflammatory bowel disease.
Kusaka S; Nishida A; Takahashi K; Bamba S; Yasui H; Kawahara M; Inatomi O; Sugimoto M; Andoh A
Clin Exp Immunol; 2018 Jan; 191(1):96-106. PubMed ID: 28872665
[TBL] [Abstract][Full Text] [Related]
7. Analysis of Spatial Organization of Suppressive Myeloid Cells and Effector T Cells in Colorectal Cancer-A Potential Tool for Discovering Prognostic Biomarkers in Clinical Research.
Zwing N; Failmezger H; Ooi CH; Hibar DP; Cañamero M; Gomes B; Gaire F; Korski K
Front Immunol; 2020; 11():550250. PubMed ID: 33193316
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA 301A Promotes Intestinal Inflammation and Colitis-Associated Cancer Development by Inhibiting BTG1.
He C; Yu T; Shi Y; Ma C; Yang W; Fang L; Sun M; Wu W; Xiao F; Guo F; Chen M; Yang H; Qian J; Cong Y; Liu Z
Gastroenterology; 2017 May; 152(6):1434-1448.e15. PubMed ID: 28193514
[TBL] [Abstract][Full Text] [Related]
9. Wnt-driven LARGE2 mediates laminin-adhesive O-glycosylation in human colonic epithelial cells and colorectal cancer.
Dietinger V; García de Durango CR; Wiechmann S; Boos SL; Michl M; Neumann J; Hermeking H; Kuster B; Jung P
Cell Commun Signal; 2020 Jun; 18(1):102. PubMed ID: 32586342
[TBL] [Abstract][Full Text] [Related]
10. Human cathelicidin improves colonic epithelial defenses against Salmonella typhimurium by modulating bacterial invasion, TLR4 and pro-inflammatory cytokines.
Marin M; Holani R; Blyth GAD; Drouin D; Odeón A; Cobo ER
Cell Tissue Res; 2019 Jun; 376(3):433-442. PubMed ID: 30788579
[TBL] [Abstract][Full Text] [Related]
11. PU.1-driven Th9 Cells Promote Colorectal Cancer in Experimental Colitis Models Through Il-6 Effects in Intestinal Epithelial Cells.
Gerlach K; Popp V; Wirtz S; Al-Saifi R; Gonzalez Acera M; Atreya R; Dregelies T; Vieth M; Fichtner-Feigl S; McKenzie ANJ; Rosenbauer F; Weigmann B; Neurath MF
J Crohns Colitis; 2022 Dec; 16(12):1893-1910. PubMed ID: 35793807
[TBL] [Abstract][Full Text] [Related]
12. Expression of the cathelicidin LL-37 is modulated by short chain fatty acids in colonocytes: relevance of signalling pathways.
Schauber J; Svanholm C; Termén S; Iffland K; Menzel T; Scheppach W; Melcher R; Agerberth B; Lührs H; Gudmundsson GH
Gut; 2003 May; 52(5):735-41. PubMed ID: 12692061
[TBL] [Abstract][Full Text] [Related]
13. Organoid modelling identifies that DACH1 functions as a tumour promoter in colorectal cancer by modulating BMP signalling.
Hu X; Zhang L; Li Y; Ma X; Dai W; Gao X; Rao X; Fu G; Wang R; Pan M; Guo Q; Xu X; Zhou Y; Gao J; Zhang Z; Cai S; Peng J; Hua G
EBioMedicine; 2020 Jun; 56():102800. PubMed ID: 32512510
[TBL] [Abstract][Full Text] [Related]
14. T cell receptor-zeta and granzyme B expression in mononuclear cell infiltrates in normal colon mucosa and colon carcinoma.
Mulder WM; Bloemena E; Stukart MJ; Kummer JA; Wagstaff J; Scheper RJ
Gut; 1997 Jan; 40(1):113-9. PubMed ID: 9155587
[TBL] [Abstract][Full Text] [Related]
15. Genetic editing of colonic organoids provides a molecularly distinct and orthotopic preclinical model of serrated carcinogenesis.
Lannagan TRM; Lee YK; Wang T; Roper J; Bettington ML; Fennell L; Vrbanac L; Jonavicius L; Somashekar R; Gieniec K; Yang M; Ng JQ; Suzuki N; Ichinose M; Wright JA; Kobayashi H; Putoczki TL; Hayakawa Y; Leedham SJ; Abud HE; Yilmaz ÖH; Marker J; Klebe S; Wirapati P; Mukherjee S; Tejpar S; Leggett BA; Whitehall VLJ; Worthley DL; Woods SL
Gut; 2019 Apr; 68(4):684-692. PubMed ID: 29666172
[TBL] [Abstract][Full Text] [Related]
16. EGFR in Tumor-Associated Myeloid Cells Promotes Development of Colorectal Cancer in Mice and Associates With Outcomes of Patients.
Srivatsa S; Paul MC; Cardone C; Holcmann M; Amberg N; Pathria P; Diamanti MA; Linder M; Timelthaler G; Dienes HP; Kenner L; Wrba F; Prager GW; Rose-John S; Eferl R; Liguori G; Botti G; Martinelli E; Greten FR; Ciardiello F; Sibilia M
Gastroenterology; 2017 Jul; 153(1):178-190.e10. PubMed ID: 28400195
[TBL] [Abstract][Full Text] [Related]
17. Synthetic cathelicidin LL-37 reduces Mycobacterium avium subsp. paratuberculosis internalization and pro-inflammatory cytokines in macrophages.
Cirone KM; Lahiri P; Holani R; Tan YL; Arrazuria R; De Buck J; Barkema HW; Cobo ER
Cell Tissue Res; 2020 Jan; 379(1):207-217. PubMed ID: 31478135
[TBL] [Abstract][Full Text] [Related]
18. IL-17A-mediated mitochondrial dysfunction induces pyroptosis in colorectal cancer cells and promotes CD8 + T-cell tumour infiltration.
Feng WQ; Zhang YC; Xu ZQ; Yu SY; Huo JT; Tuersun A; Zheng MH; Zhao JK; Zong YP; Lu AG
J Transl Med; 2023 May; 21(1):335. PubMed ID: 37211606
[TBL] [Abstract][Full Text] [Related]
19. Cell differentiation is a key determinant of cathelicidin LL-37/human cationic antimicrobial protein 18 expression by human colon epithelium.
Hase K; Eckmann L; Leopard JD; Varki N; Kagnoff MF
Infect Immun; 2002 Feb; 70(2):953-63. PubMed ID: 11796631
[TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of CD8+ T-cells density in stage III colorectal cancer depends on SDF-1 expression.
Lalos A; Tülek A; Tosti N; Mechera R; Wilhelm A; Soysal S; Daester S; Kancherla V; Weixler B; Spagnoli GC; Eppenberger-Castori S; Terracciano L; Piscuoglio S; von Flüe M; Posabella A; Droeser RA
Sci Rep; 2021 Jan; 11(1):775. PubMed ID: 33436863
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
